image

The best stocks to buy since 1993

Latest issue now available

Synergy Health - Growth rates lifted by sterilisation business

July 2011

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SYR
  • Price:
  • 910p
An outstanding set of results for the year to 31 March, sending the shares higher. With the orderbook of £920m and the company now guiding to double digit revenue growth over the next twelve months and with margins also rising sharply, we suspect it won’t be long before the shares become a doubler on our most recent main tip at 499p in July '09 whilst we have already four-bagged on our original 173p buy recommendation in August '01.  As it was, for the year to 31 March, Synergy grew sales by 4% to £287m on a constant currency basis but pretax profit increased 15% to £37.6m and eps by 17%   to 52.6p. Operating margins rose 110 basis points to an all time record 15.1% and interestingly one broker notes that Syner ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe